FRO:NYSEFrontline Plc Analysis

Frontline plc trades at $37.74, well below its DCF fair value of $74.06, implying a ~11% upside to target and a substantial discount to intrinsic value. The stock sits above its 20‑day SMA (36.91) and 50‑day SMA (35.28), confirming a bullish price structure, while the RSI at 55.8 indicates modest momentum without overbought pressure. MACD shows a bearish histogram but the overall trend remains bullish, and stable volume supports the price action. Revenue surged 46.7% year‑over‑year, delivering a gross margin of 49.5% and operating margin of 44.5%, underscoring robust operational efficiency. Free cash flow of $544 M and a payout ratio of 54.7% sustain the 4.66% dividend yield, making the income component attractive.
Recent analyst sentiment softened as Evercore ISI downgraded the outlook to In‑Line, with a modest 10.4% upside implied by the consensus one‑year target of $38.25, suggesting near‑term price pressure. Nonetheless, the company’s low beta (0.35), strong balance sheet cash position, and a forward PE of 12.2 versus industry average of 22 support a longer‑run buy case. The combination of high earnings growth, solid dividend, and a valuation gap positions Frontline as an undervalued, growth‑oriented play with sustainable income.